We are live on ! Find out more
YTEN

Yield10 Bioscience, Inc. Common Stock
YTEN

Delisted

YTEN was delisted on the 15th of May, 2024.

Back to rankings

14 hedge funds and large institutions have $9.75M invested in Yield10 Bioscience, Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

8% more funds holding

Funds holding: 13 → 14 (+1)

5% more capital invested

Capital invested by funds: $9.28M → $9.75M (+$474K)

0% more call options, than puts

Call options by funds: $1K | Put options by funds: $1K

Holders
14
Holders Change
+1
Holders Change %
+7.69%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
–
Closed
1
Calls
$1K
Puts
$1K
Net Calls
–
Net Calls Change
+$4K

Top Buyers

Rank Fund Capital Flow
1
BIT
BlackRock Institutional Trust
California
+$158K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$158K
3
AG
Aperio Group
California
+$79.2K
4
Citadel Advisors
Citadel Advisors
Florida
+$79.2K

Top Sellers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
-$158K
2
TRCT
Tower Research Capital (TRC)
New York
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$3.82M – – –
OIM
2
Oracle Investment Management
Connecticut
$2.16M – – –
BIT
3
BlackRock Institutional Trust
California
$1.11M +$158K +2 +15%
FA
4
FCG Advisors
New Jersey
$1.01M – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$713K +$158K +2 +25%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$170K – – –
AG
7
Aperio Group
California
$108K +$79.2K +1 New
MCM
8
McRae Capital Management
New Jersey
$94K – – –
BFA
9
BlackRock Fund Advisors
California
$78K – – –
Northern Trust
10
Northern Trust
Illinois
$75K – – –
Renaissance Technologies
11
Renaissance Technologies
New York
$67K – – –
Bank of New York Mellon
12
Bank of New York Mellon
New York
$63K – – –
Morgan Stanley
13
Morgan Stanley
New York
$53K – – –
Citadel Advisors
14
Citadel Advisors
Florida
$38K +$79.2K +1 New
T. Rowe Price Associates
15
T. Rowe Price Associates
Maryland
$30K – – –
State Street
16
State Street
Massachusetts
$23K – – –
Dimensional Fund Advisors
17
Dimensional Fund Advisors
Texas
$22K – – –
VKH
18
Virtu KCG Holdings
New York
$20K -$158K -2 Closed
William Blair & Company
19
William Blair & Company
Illinois
$20K – – –
GC
20
Guggenheim Capital
Illinois
$19K – – –
HighTower Advisors
21
HighTower Advisors
Illinois
$15K – – –
TWA
22
TCI Wealth Advisors
Arizona
$10K – – –
BPBT
23
Boston Private Bank & Trust
Massachusetts
$7K – – –
BA
24
BlackRock Advisors
Delaware
$6K – – –
Group One Trading
25
Group One Trading
Illinois
$6K – – –
1
2

YTEN Hedge Fund Activity: Q1 2014 in Review

14 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q1 2014, worth a combined $9.75M — up 5.1% from $9.28M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new YTEN positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.

The largest buyer was BlackRock Institutional Trust, adding an estimated $158K. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $158K sold.

  • 14 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q1 2014, up from 13 in Q4 2013.
  • Funds reported $9.75M of Yield10 Bioscience, Inc. Common Stock stock for Q1 2014, up 5.1% quarter-over-quarter.
  • 2 funds opened new Yield10 Bioscience, Inc. Common Stock positions in Q1 2014 and 1 closed out, a net change of +1 holder.
  • The largest Yield10 Bioscience, Inc. Common Stock buyer in Q1 2014 was BlackRock Institutional Trust, an estimated $158K added.
  • The largest Yield10 Bioscience, Inc. Common Stock seller in Q1 2014 was Virtu KCG Holdings, an estimated $158K sold.

Based on aggregated 13F filings for Q1 2014.